These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7825828)

  • 1. Regulation of NK cell lymphokine responsiveness by pituitary-thyroid hormones during ontogeny in mice. Suggestion for a sequential neuroendocrine-immune cross-talk.
    Provinciali M; Di Stefano G; Fabris N
    Ann N Y Acad Sci; 1994 Nov; 741():73-80. PubMed ID: 7825828
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroxine-dependent modulation of natural killer activity.
    Provinciali M; Muzzioli M; Fabris N
    J Exp Pathol; 1987; 3(4):617-22. PubMed ID: 2457668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.
    Kuribayashi K; Gillis S; Kern DE; Henney CS
    J Immunol; 1981 Jun; 126(6):2321-7. PubMed ID: 6164729
    [No Abstract]   [Full Text] [Related]  

  • 4. Anesthesia inhibits interferon-induced natural killer cell cytotoxicity via induction of CD8+ suppressor cells.
    Markovic SN; Murasko DM
    Cell Immunol; 1993 Oct; 151(2):474-80. PubMed ID: 8402951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
    J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pituitary-thyroid axis on basal and lymphokine-induced NK cell activity in aging.
    Provinciali M; Fabris N
    Int J Neurosci; 1990 Apr; 51(3-4):273-4. PubMed ID: 2279884
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
    Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
    In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of ribavirin on NK activities of murine spleen cells in vitro].
    Chen QY; Yang JQ; Mi CM
    Yao Xue Xue Bao; 1995; 30(6):417-21. PubMed ID: 7572181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary generation in vitro of T killer lymphocytes specific against viral tumors, in the presence of interleukine 2].
    Lévy JP; Gomard E; Wybier-Franqui J
    C R Seances Acad Sci III; 1981 Mar; 292(12):759-61. PubMed ID: 6788393
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
    Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The autocrine-paracrine modulation of natural killer activity in man by peptides of the corticostatin-defensin family].
    Masera RG; Gatti G; Bateman A; Solomon S; Sartori ML; Staurenghi A; Lazzero A; Griot G; Angeli A
    Ann Ital Med Int; 1993; 8(2):80-5. PubMed ID: 8353023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of age associated NK defect by endocrinological and/or nutritional intervention.
    Provinciali M; Pieri C; Fabris N
    Ann Ist Super Sanita; 1991; 27(1):61-6. PubMed ID: 1720296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
    Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
    Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L; Bracci M; Mocchegiani E
    Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 or IL-15, unlike IL-2, does not interact with histamine in augmenting cytotoxicity of splenocytes against melanoma cells and YAC-1 cells.
    Kozar K; Kaminski R; Giermasz A; Basak G; Zagozdzon R; Rybczynska J; Wasik M; Lasek W; Jakobisiak M; Golab J
    Oncol Rep; 2002; 9(2):427-31. PubMed ID: 11836621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.